Dietary induced weight loss in non-oncological populations has shown reductions in inflammatory cytokines (IL-6 and IL-8) associated with CRF [85,86,87,88], suggesting weight loss in obese men with prostate cancer to be a plausible and measurable nutrition therapy outcome. This evidence concerns the gene CXCL8 and prostate carcinoma.